NCT00238108View on ClinicalTrials.gov

Melatonin Supplements for Improving Sleep in Individuals With Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Sleep DisordersHypertension
Interventions
DRUG

Melatonin

2,5 mg melatonin, by mouth, 1 per day, for 3-4 weeks

DRUG

Placebo

Placebo

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

Office of Dietary Supplements (ODS)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT00238108 - Melatonin Supplements for Improving Sleep in Individuals With Hypertension | Biotech Hunter | Biotech Hunter